Skip to main content

Research Repository

Advanced Search

Palladium-Mediated Bioorthogonal System for Prodrug Activation of N-Benzylbenzamide-Containing Tubulin Polymerization Inhibitors for the Treatment of Solid Tumors

Li, Jinlong; Zhang, Tong; Wu, Di; He, Chen; Weng, Haoxiang; Zheng, Tiandong; Liu, Jie; Yao, Hong; Chen, Jichao; Ren, Yansong; Zhu, Zheying; Xu, Jinyi; Xu, Shengtao

Authors

Jinlong Li

Tong Zhang

Di Wu

Chen He

Haoxiang Weng

Tiandong Zheng

Jie Liu

Hong Yao

Jichao Chen

Yansong Ren

Dr ZHEYING ZHU Zheying.Zhu@nottingham.ac.uk
ASSOCIATE PROFESSOR IN INTERNATIONAL PHARMACY AND TRADITIONAL MEDICINES

Jinyi Xu

Shengtao Xu



Abstract

Bioorthogonal cleavage reactions have been developed as an intriguing strategy to enhance the safety of chemotherapeutics. Aiming to reduce the toxicity and improve the targeted release properties of the colchicine binding site inhibitors (CBSIs) based on previous work, a series of biologically inert prodrugs were further designed and synthesized through a bioorthogonal prodrug strategy. The therapeutic effects of prodrugs could be “turned-on” once combined with palladium resins. Particularly, prodrug 2b was 68.3-fold less cytotoxic compared to the parent compound, while its cytotoxicity was recovered in situ in the presence of palladium resins. Mechanism studies confirmed that 2b inhibited cell growth in the same manner as CBSIs. More importantly, in vivo efficacy studies demonstrated the efficient activation of 2b by palladium resins, resulting in significant inhibition of tumor growth (63.2%). These results suggest that prodrug 2b with improved safety and targeted release property catalyzed by a Pd-mediated bioorthogonal cleavage reaction deserves further investigation.

Citation

Li, J., Zhang, T., Wu, D., He, C., Weng, H., Zheng, T., Liu, J., Yao, H., Chen, J., Ren, Y., Zhu, Z., Xu, J., & Xu, S. (2024). Palladium-Mediated Bioorthogonal System for Prodrug Activation of N-Benzylbenzamide-Containing Tubulin Polymerization Inhibitors for the Treatment of Solid Tumors. Journal of Medicinal Chemistry, 67(21), 19905-19924. https://doi.org/10.1021/acs.jmedchem.4c02419

Journal Article Type Article
Acceptance Date Oct 22, 2024
Online Publication Date Nov 1, 2024
Publication Date Nov 14, 2024
Deposit Date Nov 24, 2024
Publicly Available Date Nov 2, 2025
Journal Journal of Medicinal Chemistry
Print ISSN 0022-2623
Electronic ISSN 1520-4804
Publisher American Chemical Society
Peer Reviewed Peer Reviewed
Volume 67
Issue 21
Pages 19905-19924
DOI https://doi.org/10.1021/acs.jmedchem.4c02419
Keywords Assays; Organic polymers; Palladium; Pharmaceuticals; Toxicity
Public URL https://nottingham-repository.worktribe.com/output/42468850
Publisher URL https://pubs.acs.org/doi/10.1021/acs.jmedchem.4c02419